GR3001277T3 - Chlorpheniramine therapy - Google Patents

Chlorpheniramine therapy

Info

Publication number
GR3001277T3
GR3001277T3 GR90401091T GR900401091T GR3001277T3 GR 3001277 T3 GR3001277 T3 GR 3001277T3 GR 90401091 T GR90401091 T GR 90401091T GR 900401091 T GR900401091 T GR 900401091T GR 3001277 T3 GR3001277 T3 GR 3001277T3
Authority
GR
Greece
Prior art keywords
chlorpheniramine
therapy
delivering
disclosed
dosage form
Prior art date
Application number
GR90401091T
Other languages
English (en)
Inventor
Sally I Stephens
Lawrence G Hamel
Glen E Barclay
Patrick S-L Wong
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of GR3001277T3 publication Critical patent/GR3001277T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR90401091T 1986-04-17 1991-01-03 Chlorpheniramine therapy GR3001277T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85310986A 1986-04-17 1986-04-17

Publications (1)

Publication Number Publication Date
GR3001277T3 true GR3001277T3 (en) 1992-08-26

Family

ID=25315081

Family Applications (1)

Application Number Title Priority Date Filing Date
GR90401091T GR3001277T3 (en) 1986-04-17 1991-01-03 Chlorpheniramine therapy

Country Status (10)

Country Link
EP (1) EP0247709B1 (el)
JP (1) JPH0784385B2 (el)
KR (1) KR890004683B1 (el)
AT (1) ATE59550T1 (el)
AU (1) AU597952B2 (el)
CA (1) CA1285484C (el)
DE (1) DE3766885D1 (el)
ES (1) ES2019634B3 (el)
GR (1) GR3001277T3 (el)
ZA (1) ZA872128B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0921803D0 (en) * 2009-12-14 2010-01-27 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
PL3102187T3 (pl) 2014-02-03 2020-10-19 Galenicum Health S.L. Stabilne kompozycje farmaceutyczne zawierające sitagliptynę w postaci tabletek o natychmiastowym uwalnianiu

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA836627B (en) * 1982-10-08 1984-05-30 Verex Lab Constant release rate solid oral dosage formulation of pharmaceutical compounds having a high degree of water solubility
US4576604A (en) * 1983-03-04 1986-03-18 Alza Corporation Osmotic system with instant drug availability
GB2150830B (en) * 1983-12-05 1987-08-19 Alza Corp Drug dispenser
CA1266827A (en) * 1984-06-20 1990-03-20 Merck & Co., Inc. Controlled porosity osmotic pump
US4743248A (en) * 1986-08-11 1988-05-10 Alza Corporation Dosage form for delivering acid sensitive beneficial agent

Also Published As

Publication number Publication date
ES2019634B3 (es) 1991-07-01
AU597952B2 (en) 1990-06-14
AU7071487A (en) 1987-10-22
KR870009716A (ko) 1987-11-30
EP0247709A1 (en) 1987-12-02
KR890004683B1 (ko) 1989-11-25
EP0247709B1 (en) 1991-01-02
ZA872128B (en) 1987-11-25
JPH0784385B2 (ja) 1995-09-13
ATE59550T1 (de) 1991-01-15
DE3766885D1 (en) 1991-02-07
CA1285484C (en) 1991-07-02
JPS62249924A (ja) 1987-10-30

Similar Documents

Publication Publication Date Title
GB8501930D0 (en) Delivery & dosage device
GR890100838A (el) Νέα ?εραπευτικώς δραστική ένωσις και μέ?οδος για την παραγωγή της.
EP0294272A3 (en) Needleless injector, especially for dental use
GR3002487T3 (en) Medicament with anti-tumoral action containing hexadecylphosphocholine
EP0242643A3 (en) Nasal administration of drugs
ZA89749B (en) Drip emitter
NO851658L (no) Innretning for medisinavlevering.
IE882391L (en) Pad printing process
JO1438B1 (en) Therapeutic agents
PT76504B (en) Perfluorohydrocarbons as vehicles for administering drugs
JO1482B1 (en) Therapeutic agents
GR3001277T3 (en) Chlorpheniramine therapy
JO1483B1 (en) Therapeutic agents
EP0238656A4 (en) METHOD FOR ADMINISTERING VACCINES AND COMPOSITIONS PROVIDED THEREFOR.
NZ214652A (en) Vaccine against fasciola
GR3007995T3 (el)
GB2178955B (en) Device for administering calcium ascorbate
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
EP0333997A3 (en) Bipolar transistor
NO164972C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo-1,8-diamino-4-aza-octaner.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
ES8606248A1 (es) Un procedimiento para la produccion de una dihidroxifenil- glicina opticamente activa
GB8414737D0 (en) Dose administering device
DE3882331D1 (en) Dose.